Geron Corporation

Financials

Flusso di cassa derivante dalle attività operative -66.65 M-95.56 M-127.38 M-167.74 M-218.62 M-111.04 M -111.04 M Flussi di cassa derivanti dalle attività di investimento -105.32 M71.95 M62.07 M-180.32 M-106 M107.25 M 107.25 M Liquidità derivante dalle attività di finanziamento 168.35 M48.56 M87.26 M362.02 M334.37 M2.27 M 2.27 M Liquidità libera -67.05 M-95.76 M-127.81 M-168.57 M-219.3 M-111.04 M -111.04 M

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN

Financials

Geron Corporation

Notizie

Geron nomina Timothy Williams chief legal officer

I modelli Fair Value di InvestingPro individuano un guadagno del 53% in Geron Corporation

Geron nomina Patricia S. Andrews e Constantine Chinoporos nel consiglio di amministrazione

Geron aggiunge due amministratori con esperienza commerciale al CdA

Geron alla conferenza Barclays Healthcare: crescita strategica e piani futuri

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

Geron al TD Cowen: Crescita Strategica ed Espansione di Mercato

Geron at TD Cowen: Strategic Growth and Market Expansion

Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)

Geron Corporation (GERN) Q4 2025 Earnings Call Transcript